Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Xvivo Perfusion AB

Closing information (x1000 DKK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 401,354 Less Arrow 277,512 Less Arrow 187,881
Financial expenses 31,087 More Arrow 37,216 Less Arrow 14,692
Earnings before taxes 63,487 Less Arrow 14,911 Less Arrow 4,846
EBITDA 43,052 Less Arrow 32,460 Less Arrow -5,424
Total assets 1,474,736 Less Arrow 1,158,104 Less Arrow 1,121,670
Current assets 555,075 Less Arrow 312,404 More Arrow 398,128
Current liabilities 90,332 Less Arrow 90,142 Less Arrow 75,999
Equity capital 1,306,437 Less Arrow 955,664 Less Arrow 934,691
- share capital 541 Less Arrow 509 More Arrow 548
Employees (average) 130 Less Arrow 114 Less Arrow 92

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 88.6% Less Arrow 82.5% More Arrow 83.3%
Turnover per employee 3,087 Less Arrow 2,434 Less Arrow 2,042
Profit as a percentage of turnover 15.8% Less Arrow 5.4% Less Arrow 2.6%
Return on assets (ROA) 6.4% Less Arrow 4.5% Less Arrow 1.7%
Current ratio 614.5% Less Arrow 346.6% More Arrow 523.9%
Return on equity (ROE) 4.9% Less Arrow 1.6% Less Arrow 0.5%
Change turnover 122,413 Less Arrow 104,850 Less Arrow 57,098
Change turnover % 44% More Arrow 61% Less Arrow 44%
Chg. No. of employees 16 More Arrow 22 More Arrow 29
Chg. No. of employees % 14% More Arrow 24% More Arrow 46%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.